Abstract
Abstract
Background
Coronavirus disease (COVID-19) currently named SARS-CoV-2 is a contagious disease caused by a coronavirus. The virus may infect the hair follicles directly or indirectly through systemic changes in the immune or hormonal systems.
Aims
In the current study we aimed to determine the prevalence of hair disorders in females infected with COVID-19.
Methods
Data was collected using a questionnaire covering four main domains: personal data, past medical history, COVID-19 history and treatment, and existence of any hair problems and their management. No identifier or sensitive data were collected. Those complaining of hair loss were subjected to complete general and local hair examination using trichoscopy to confirm hair loss.
Results
Hair problems were reported in 307 (61.4%) of COVID-19-infected female subjects. A total of 68.1% patients reported that hair loss existed and increased after COVID-19; 29.6% reported their hair problems only post-COVID-19 while 2.3% had hair shedding issues during infection only. The main reported hair problems were telogen effluvium (60.8%), increased gray hair (13.8%), seborrheic dermatitis (5.6%) trichotillomania (3.6%), and alopecia areata (2.2%).
Conclusion
In conclusion, we reported prevalence of post-COVID hair fall that was confirmed by trichoscopy and which affected approximately 61.4% of infected females.
Funder
National Research Centre Egypt
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Sachdeva M, Gianotti R, Shah M et al (2020) Cutaneous manifestations of COVID-19: report of three cases and a review of literature. J Dermatol Sci 98(2):75–81
2. Elsaie ML, Youssef EA, Nada HA et al (2020) Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther 33(4):e13666
3. Xiong Q, Xu M, Li J et al (2021) Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 27(1):89–95
4. Seyfi S, Alijanpour R, Aryanian Z, Ezoji K, Mahmoudi M et al (2022) Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity. J Med Life 15:631–634
5. Iancu GM, Molnar E, Ungureanu L et al (2023) SARS-CoV-2 infection—a trigger factor for telogen effluvium: review of the literature with a case-based guidance for clinical evaluation. Life (Basel) 13(7):1576
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献